Navigation Links
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Date:2/26/2009

nt portfolios by taking cash for their shares at a time when cash provides certainty and stability," said Kevin Buchi, chief financial officer at Cephalon. "We are better equipped to take Arana's lead compound, ART621, through clinical development and, pending the success of clinical trials, to international markets."

To support its bid, Cephalon has acquired a shareholding in Arana, representing an ownership position of approximately 19.9 percent of the total issued share capital of Arana. The purchase price of the shares was A$1.40 per share. Cephalon has acquired this stake from Arana's two largest shareholders, Start-up Australia Ventures Pty Ltd and Rockwell Securities Limited.

Cephalon's offer will be subject to certain basic conditions (outlined in Appendix A), including a 50.1 percent minimum acceptance condition.

Cephalon is well advanced in the preparation of its Bidder's Statement, and expects the offer will be open for acceptance by mid-March.

Arana is a biopharmaceutical company focused on developing next generation antibody based drugs that will improve the lives of patients with inflammatory diseases and cancer. The company's lead compound, ART621, is a new generation tumor necrosis factor (TNF ) alpha blocker in development for patients with inflammatory diseases. Arana has a strong patent portfolio related to anti-TNF alpha antibodies and receives royalties from Abbott Laboratories and Johnson & Johnson, the makers of HUMIRA(R) and REMICADE(R), respectively. Cephalon expects these royalties largely to offset costs of development in the near term. Therefore, Cephalon is making no change to its 2009 adjusted net income guidance.

"Arana would bolster our burgeoning inflammatory disease pipeline as well as our oncology pipeline," said Frank Baldino, Jr., Ph.D., chairman and CEO of Cephalon. "Arana has an established protein engineering technology platform
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Horizon Blue Cross Blue Shield ... secure credit rating of “A” from Standard & Poor’s. ... week, the Wall Street ratings agency cited the company’s ... in determining the rating and “stable” outlook. , “Providing ... our top priorities, so we are pleased to have ...
(Date:5/5/2015)... May 05, 2015 Hundreds ... filed on behalf of men who allegedly ... use of prescription testosterone replacement therapies continue ... litigation underway in U.S. District Court, Northern ... dated May 1st, defendants AbbVie, Inc., Auxilium ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great conditions last ... walkers participated in Global Lyme Alliance’s (GLA) inaugural “Lyme ... 5K and 10K runs and 1-and 3-mile walks were held ... for tick-borne disease research. The “Lyme Walk and Run” was ... of Lyme Research Alliance (LRA) and Tick-Borne Disease Alliance (TBDA), ...
(Date:5/5/2015)... Battle Creek, Michigan (PRWEB) May 05, 2015 ... IN, media outlet The Herald-Times , the Missouri State ... incidents involving Crystal Methamphetamine production or use for the second ... national meth statistics to the FBI, reported 1,469 incidents in ... this into perspective, only around 2% of the US Population ...
(Date:5/5/2015)... 05, 2015 The brains of people ... that correlate with slower information processing, according to research ... of Public Health . , The findings indicate ... 1 diabetes for cognitive difficulties. If progressive, these changes ... study, funded by the National Institutes of Health ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4
... Environmental agencies in Tamil Nadu are demanding monitoring stations ... samples //from the state among the most polluted in ... Pollution Control Board to apply for central funds to ... monitoring stations in Manali, Mettur, Cuddalore, Tuticorin and other ...
... condition of VHP leader Praveen Togadiya, who underwent an angioplasty ... hospital sources said today. // ,Togadiya was admitted ... ,Cardiologist of the Hospital Dr Bhupesh Shah carried out the ... at the hospital, the condition of the leader is stable ...
... University in California, monstrous matter-sucking black holes in the space ... research//. ,When used in a car it will ... gallon (4.5 litres) of gas. ,Huge bubbles in ... or even thousands of light-years across. ,Allen and ...
... University's Vegetable and Fruit Improvement Center researchers revealed when ... it improves bone strength and prevents osteoporosis//. ... women in the United States, according to the National ... wrists break each year as a result, said Dr. ...
... resistant to mad cow disease. The success story was ... eastern province of Shandong ,Researchers at the Laiyang ... to introduce the genes to the calf cloned from cells ... Dong Yajuan and Bo Xuejin , who had first tasted ...
... attack for the time and has survived cannot be termed as ... them//. A new study has found that one out of ten ... of blood to be pumped to the vital organs. As a ... organs stop functioning. It is said that cardiogenic shock is the ...
Cached Medicine News:Health News:Air Pollution in Tamil Nadu is a Cause of Concern for Environmentalists 2Health News:Bone Strength Increases In Rats With Citrus Juice Breakfast – Study Say 2Health News:Cardiogenic Shock is the Leading Cause of Death for Heart Attack Patients 2Health News:Cardiogenic Shock is the Leading Cause of Death for Heart Attack Patients 3
(Date:5/5/2015)... 5, 2015  IBM Watson Health (NYSE: IBM ) ... and Mayo Clinic to advance patient health by ... Records (EHRs). As Watson,s capabilities are applied ... thorough analysis of the medical factors that could impact an ... than 350 customers – some of the largest and most-recognized ...
(Date:5/5/2015)... 2015 Research and Markets ( ... "Radiation Dose Management Market by Product (Dose ... Application (Computed Tomography, Angiography, Fluoroscopy), by End User ... report to their offering. The ... grow at a CAGR of around 50% during ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... the "Home Healthcare Global Market - Forecast to ... home healthcare market is expected to reach more than ... The home healthcare equipment market is expected ... healthcare services market. Home healthcare is gaining a tremendous ...
Breaking Medicine Technology:IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4Radiation Dose Management (Dose Tracking, Monitoring, and Analytics Software, Consulting Services) Market - Global Forecasts to 2020 2Radiation Dose Management (Dose Tracking, Monitoring, and Analytics Software, Consulting Services) Market - Global Forecasts to 2020 3Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2
... RELISA ENA Single Well Screening Kit is designed ... most common autoantibodies. Each microtiter well is coated ... autoantigens. This allows the laboratory to cost effectively ... to determining the ENA specificity on any of ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
... Lipid Control is intended for use in ... sample of known concentration for monitoring assay ... Liquid Lipid Control with patient serum specimens ... constituents. The user can compare observations with ...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
Medicine Products: